Document is current
Any future updates will be listed below
-
Authors
Stocchi, Fabrizio https://orcid.org/0000-0002-5763-0033
Knecht, Mathias
Marjanovic, Ivan
Wach, Achim
Kopra, Jaakko https://orcid.org/0000-0002-4872-3326
Kulisevsky, Jaime https://orcid.org/0000-0003-4870-1431
-
Funding
Funding for this research was provided by:
Zambon Biotech SA
- License Information
-
More Information
Article History
Received: 10 December 2025
Accepted: 30 January 2026
First Online: 22 February 2026
Declarations
:
: Fabrizio Stocchi has received compensation for consultancy and speaker-related activities from UCB, Britannia, AbbVie, Zambon, Bial, Ever Pharma, Synegile, Biogen, Roche, Blue Rock, Chiesi Pharmaceuticals, Lundbeck, Sunovion and Kiowa. Jaime Kulisevsky during the last 24Â months has received honoraria for consulting and/or lecturing from: Abbvie, Zambon, Prilenia, Bial, Stada, Britannia, General Electric, SOM-Biotech, MediBiopharma, UCB and Ferrer. Mathias Knecht and Jaakko Kopra are employees, while Ivan Marjanovic and Achim Wach are consultants of Zambon Biotech SA.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
